Nagafuji, Koji http://orcid.org/0000-0003-4795-121X
Matsumura, Itaru
Shimose, Takayuki
Kawaguchi, Tatsuya
Kuroda, Junya
Nakamae, Hirohisa
Miyamoto, Toshihiro
Kadowaki, Norimitsu
Ishikawa, Jun
Imamura, Yutaka
Yamazaki, Hirohito
Akashi, Koichi
Kanakura, Yuzuru
Article History
Received: 3 April 2019
Revised: 11 September 2019
Accepted: 11 September 2019
First Online: 19 September 2019
Compliance with ethical standards
:
: KN, TS, JK, TM, JI, or YI have no competing financial interests. IM acts as a consultant to Otsuka, has received research funding from Bristol-Myers, and has received honoraria directly from Pfizer, Novartis Pharma KK, and Otsuka. HN acts as a consultant to Novartis Pharma KK, has received research funding from Novartis Pharma KK, has received honoraria directly from Novartis Pharma KK, and acts as Director of the Speakers Bureau, and is on advisory committees of Novartis Pharma KK. TK and HY have received honoraria directly from Novartis Pharma KK. NK has received research funding from Novartis Pharma KK and Pfizer, and has received honoraria directly from Novartis Pharma KK, Pfizer, and Bristol-Myers. KA has received research funding from Novartis Pharma KK. YK has received research funding from Pfizer and Bristol-Myers.